248 related articles for article (PubMed ID: 18484430)
21. Livedoid vasculopathy in a patient with lupus anticoagulant and MTHFR mutation: treatment with low-molecular-weight heparin.
Abou Rahal J; Ishak RS; Otrock ZK; Kibbi AG; Taher AT
J Thromb Thrombolysis; 2012 Nov; 34(4):541-4. PubMed ID: 22592843
[TBL] [Abstract][Full Text] [Related]
22. Factor V Leiden mutation-related chronic skin ulcers.
Kayatas K; Cebeci F; Karatoprak C; Benzer M; Demirtunç R; Demirkesen C
Int J Low Extrem Wounds; 2013 Mar; 12(1):35-8. PubMed ID: 23446370
[TBL] [Abstract][Full Text] [Related]
23. Livedoid vasculopathy with underlying subcutaneous necrotizing venulitis in an asymptomatic hepatitis B virus carrier: is livedoid vasculopathy a true nonvasculitic disorder?
Ishibashi M; Miyamoto J; Nagasaka T; Chen KR
Am J Dermatopathol; 2009 May; 31(3):293-6. PubMed ID: 19384073
[TBL] [Abstract][Full Text] [Related]
24. A fatal case of malignant atrophic papulosis (Degos' disease) in a man with factor V Leinden mutation and lupus anticoagulant.
Hohwy T; Jensen MG; Tøttrup A; Steiniche T; Fogh K
Acta Derm Venereol; 2006; 86(3):245-7. PubMed ID: 16710585
[TBL] [Abstract][Full Text] [Related]
25. Severe livedoid vasculopathy associated with antiphosphatidylserine-prothrombin complex antibody successfully treated with warfarin.
Noda S; Asano Y; Yamazaki M; Ichimura Y; Tamaki Z; Takekoshi T; Sugaya M; Sato S
Arch Dermatol; 2011 May; 147(5):621-3. PubMed ID: 21576587
[No Abstract] [Full Text] [Related]
26. Livedoid vasculopathy and skin ulcers in patients with inherited thrombophilia.
Cocuroccia B; Tonanzi T; Menaguale G; Fazio M; Girolomoni G
Eur J Dermatol; 2002; 12(4):360-3. PubMed ID: 12095882
[No Abstract] [Full Text] [Related]
27. Livedoid vasculopathy: long-term follow-up results following hyperbaric oxygen therapy.
Juan WH; Chan YS; Lee JC; Yang LC; Hong HS; Yang CH
Br J Dermatol; 2006 Feb; 154(2):251-5. PubMed ID: 16433793
[TBL] [Abstract][Full Text] [Related]
28. A case of deep vein thrombosis in idiopathic nephrotic syndrome with resistance to activated protein C.
Campisi S; Cavatorta F
J Nephrol; 1998; 11(2):76-7. PubMed ID: 9589377
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous necrosis revealing the coexistence of an antiphospholipid syndrome with acquired protein S deficiency, factor V Leiden and hyperhomocysteinemia.
Combemale P; Amiral J; Estival JL; Dupin M; Chouvet B; Berruyer M
Eur J Dermatol; 2002; 12(3):278-82. PubMed ID: 11978573
[TBL] [Abstract][Full Text] [Related]
30. Livedoid vasculopathy: A review of pathogenesis and principles of management.
Vasudevan B; Neema S; Verma R
Indian J Dermatol Venereol Leprol; 2016; 82(5):478-88. PubMed ID: 27297279
[TBL] [Abstract][Full Text] [Related]
31. Livedoid vasculopathy associated with heterozygous protein C deficiency.
Boyvat A; Kundakçi N; Babikir MO; Gürgey E
Br J Dermatol; 2000 Oct; 143(4):840-2. PubMed ID: 11069468
[TBL] [Abstract][Full Text] [Related]
32. Necrotic cutaneous vasculitic skin lesions: a case of atypical Henoch-Schönlein purpura in a child with heterozygosity for factor V Leiden.
Dhanjal S; Saso A; Eleftheriou D; Laurent S
BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28536112
[No Abstract] [Full Text] [Related]
33. Recurrent ulcerations on both legs since early childhood due to a factor V gene mutation.
Hackenjos K; Bek M; Schöpf E; Vanscheidt W
Dermatology; 1997; 194(3):297-8. PubMed ID: 9187855
[TBL] [Abstract][Full Text] [Related]
34. [Liveoid vasculopathy with combined thrombophilia: efficacy of iloprost].
Magy N; Algros MP; Racadot E; Gil H; Kantelip B; Dupond JL
Rev Med Interne; 2002 Jun; 23(6):554-7. PubMed ID: 12108180
[TBL] [Abstract][Full Text] [Related]
35. Chronic leg ulcerations associated with livedoid vasculopathy successfully treated with rivaroxaban.
Miguel D; Elsner P; Goetze S
Clin Exp Dermatol; 2020 Jan; 45(1):120-122. PubMed ID: 30767258
[No Abstract] [Full Text] [Related]
36. A case of ischemic colitis associated with factor V Leiden mutation: successful treatment with anticoagulation.
Chin BW; Greenberg D; Wilson RB; Meredith CG
Gastrointest Endosc; 2007 Aug; 66(2):416-8. PubMed ID: 17524402
[No Abstract] [Full Text] [Related]
37. [Is lifetime anticoagulation required in factor V Leiden mutation?].
Pötzsch B
Dtsch Med Wochenschr; 2003 Jul; 128(30):1617. PubMed ID: 12884152
[No Abstract] [Full Text] [Related]
38. Factor V Leiden mutation and type 1 diabetes mellitus.
Demirer AN; Alikasifoglu M; Tuncbilek E; Karakus S; Erbas T
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):70-4. PubMed ID: 18180619
[TBL] [Abstract][Full Text] [Related]
39. Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases.
Hairston BR; Davis MD; Gibson LE; Drage LA
Arch Dermatol; 2003 Aug; 139(8):987-90. PubMed ID: 12925383
[No Abstract] [Full Text] [Related]
40. [Livedoid vasculopathy. Pathogenesis, diagnosis and treatment of cutaneous infarction].
Goerge T
Hautarzt; 2011 Aug; 62(8):627-34; quiz 635. PubMed ID: 21786003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
